Category

Daily Briefs

Daily Brief Industrials: ANE Cayman Inc, Wacker Neuson Se, Sai Gon Cargo Service , Cahaya Aero Services, CEL Corp, China National Chemical Engineering Company A, Deutsche Lufthansa , Fagerhult Group , Hydrofarm Holdings Group Inc, Shenzhen Jasic Technology A and more

By | Daily Briefs, Industrials

In today’s briefing:

  • ANE Cayman (9956 HK): Q&A With The FA
  • Doosan Bobcat: To Acquire the Controlling Stake & Conduct Tender Offer of Wacker Neuson?
  • Sai Gon Cargo Service (SCS VN): Robust Start To Q4, 7.2x PE/11% Dividend Yield/Net Cash/50% ROCE
  • Primer: Cahaya Aero Services (CASS IJ) – Dec 2025
  • (02 Dec 2025) CEL Corp(5078 JP) — Fisco Company Research
  • Primer: China National Chemical Engineering Company A (601117 CH) – Dec 2025
  • Primer: Deutsche Lufthansa (LHA GR) – Dec 2025
  • Primer: Fagerhult Group (FAG SS) – Dec 2025
  • HYFM: Continuing Market Pressures Drive Weaker 3Q25 Results and CEO Change
  • Primer: Shenzhen Jasic Technology A (300193 CH) – Dec 2025


ANE Cayman (9956 HK): Q&A With The FA

By David Blennerhassett

  • On the 28th October, ANE Cayman Inc (9956 HK), a road freight transportation play, announced a Scheme from Centurium Partners, a pre-IPO investor, Temasek, and Singapore-based asset manager True Light.
  • The consortium offered HK$12.18/share, a 48.54% premium to undisturbed. A special dividend was bolted on. All pre-cons, including SAMR’s approval, have been satisfied. Scheme Doc dispatch expected on/before 31st December.
  • I had a number of questions concerning the transaction, and yesterday pinned down a one-on-one with the FA to the Offeror.

Doosan Bobcat: To Acquire the Controlling Stake & Conduct Tender Offer of Wacker Neuson?

By Douglas Kim

  • According to numerous local media, Doosan Bobcat is pursuing the acquisition of a controlling stake in Wacker Neuson Se (WAC GR), a German based compact construction equipment company. 
  • Doosan Bobcat is apparently discussing a plan to acquire approximately 60% of Wacker Neuson. There are also discussions to secure the remaining shares of the company through a tender offer. 
  • Wacker Neuson has a market cap of 1.46 billion EUR (2.5 trillion won) and the acquisition value for a 100% stake is expected to be more than 5 trillion won.

Sai Gon Cargo Service (SCS VN): Robust Start To Q4, 7.2x PE/11% Dividend Yield/Net Cash/50% ROCE

By Sameer Taneja

  • Sai Gon Cargo Service (SCS VN) experienced a robust start to Q4 with October volumes up 8.8% YoY (led by international volume growth of 16% YoY). 
  • On the 9MFY25 trajectory, despite the increase in corporate tax from 11% to 20%, the company will still achieve 5-6% YoY earnings growth, placing it at 7.2x PE FY25e.
  • The company faces ongoing risk from potential volume migration to Long Thanh Airport Terminal 2, slated to begin operations in early 2027, which is expected to divert international cargo.

Primer: Cahaya Aero Services (CASS IJ) – Dec 2025

By αSK

  • Cahaya Aero Services (CASS) is a dominant integrated aviation support provider in Indonesia, poised to capitalize on the nation’s robust recovery and projected long-term growth in air travel.
  • The company is demonstrating exceptional financial performance, characterized by accelerating revenue growth, significant margin expansion, and triple-digit growth in net income and EPS over the past three years.
  • While the company’s strategic focus on reinvesting for growth has fueled impressive operational expansion, this comes at the expense of shareholder distributions, with no dividends paid in recent years.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


(02 Dec 2025) CEL Corp(5078 JP) — Fisco Company Research

By FISCO

Key points (machine generated)

  • Cel Corporation, listed as 5078 on the Tokyo Stock Exchange, specializes in apartment manufacturing and land use consulting.
  • The company has faced decreased revenue and profit due to delays in rental development but maintains its full-year forecast for recovery.
  • Cel Corporation targets young people and the steel-framed apartment sector, with support from its subsidiary, Celent Partners Co., Ltd.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


Primer: China National Chemical Engineering Company A (601117 CH) – Dec 2025

By αSK

  • China National Chemical Engineering Co., Ltd. (CNCEC) is a leading engineering and construction company, specializing in the chemical, petrochemical, and energy industries. The company has a strong track record of delivering large-scale projects both domestically and internationally.
  • The company is well-positioned to benefit from China’s continued investment in infrastructure and the chemical sector. CNCEC’s focus on technological innovation and sustainable development aligns with the country’s long-term strategic goals.
  • Despite a challenging global economic environment, CNCEC has demonstrated resilient financial performance. The company’s strong government backing and diversified project portfolio provide a stable foundation for future growth.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Deutsche Lufthansa (LHA GR) – Dec 2025

By αSK

  • Deutsche Lufthansa is a leading global aviation group with a diversified business model encompassing passenger airlines, cargo, and maintenance, repair, and overhaul (MRO) services. This diversification provides multiple revenue streams and resilience against market volatility in any single segment.
  • The company is undergoing a significant strategic transformation focused on fleet modernization, cost reduction, and enhancing operational efficiency to improve profitability.
  • Key challenges for Lufthansa include intense competition from both legacy and low-cost carriers, high operating costs, and susceptibility to external factors such as fuel price volatility, geopolitical instability, and labor disputes.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Fagerhult Group (FAG SS) – Dec 2025

By αSK

  • Fagerhult Group is a leading European professional lighting provider with a strong portfolio of 12 brands, strategically positioned to capitalize on the industry’s shift towards energy-efficient and smart lighting solutions.
  • Financial performance shows recent pressure on profitability, with declining net income and margins despite relatively stable revenues. This highlights challenges from market volatility and the need for operational efficiency.
  • The company’s strategy is focused on organic growth, sustainability, and innovation in connected lighting. Successful execution of this strategy will be critical to navigating a competitive landscape and reversing the negative trend in earnings.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


HYFM: Continuing Market Pressures Drive Weaker 3Q25 Results and CEO Change

By Water Tower Research

  • Top line and margins come in weaker than expected. 
  • Hydrofarm reported 3Q25 results that included net sales of $29.4MM, down 33.3% Y/Y, driven primarily by a 32% decline in volume/mix and (1%) Y/Y price change.
  • Adjusted gross margin of 18.8% declined sequentially and was down meaningfully versus 24.3% in 3Q24 as lower manufacturing production volumes compressed margins, despite a positive mix and largely stable prices. 

Primer: Shenzhen Jasic Technology A (300193 CH) – Dec 2025

By αSK

  • Shenzhen Jasic Technology is a prominent Chinese manufacturer of inverter welding and cutting equipment, demonstrating a strong financial profile with consistent profitability and robust cash flow generation.
  • The company is well-positioned to capitalize on the growing global and domestic welding equipment market, driven by industrial automation, infrastructure development, and a strategic focus on high-end product segments.
  • Despite solid fundamentals, the company faces risks from intense market competition, reliance on export markets, and historical labor disputes that could pose reputational challenges.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Quanta Computer, Xiaomi, PC Partner, Samsung C&T, Telkom Indonesia, Meesho, Readcloud Ltd, Fair Isaac Corp, DoubleVerify, Intel Corp and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • TIP Customized Taiwan Select High Dividend Index Rebal Preview: 8 Changes; US$8bn Trade
  • HSI, HSCEI, HSTECH, HSIII, HSBIO Index Rebalance: US$6.4bn of Flows Post Capping (Dec 2025)
  • PC Partner: Delisting in HK on 14 January 2026, Only on SGX Going Forward
  • Hong Ra-Hee To Give 1.8 Million Shares of Samsung C&T to Her Son Lee Jae-Yong
  • Primer: Telekomunikasi Indonesia (TLKM IJ) – Dec 2025
  • Meesho – Potential Play on Value E-Commerce
  • Readcloud Ltd – Driving growth through the schools businesses
  • Fair Isaac (FICO): High-Margin Scores Franchise With Structural Pricing Power…
  • Ad-Tech Primer: Investing in the Future of Digital Advertising
  • Intel (INTC.US): Apple M-Series in 2027; Intel 18A Is the Key.


TIP Customized Taiwan Select High Dividend Index Rebal Preview: 8 Changes; US$8bn Trade

By Brian Freitas

  • The TIP Taiwan Select High Dividend ETF (00919 TW) tracks the TIP Customized Taiwan Select High Dividend Index and has an AUM of TWD 403bn (US$12.8bn).
  • We forecast 8 changes a side at the December rebalance with an estimated one-way turnover of 30.6% resulting in a round-trip trade of US$7.9bn.
  • The forecast adds have outperformed the forecast deletes over the last couple of weeks and we expect the adds to continue outperforming the deletes over the next few days.

HSI, HSCEI, HSTECH, HSIII, HSBIO Index Rebalance: US$6.4bn of Flows Post Capping (Dec 2025)

By Brian Freitas

  • The December rebalance of the Hang Seng family of indices will use today’s closing prices to cap the index constituent weights.
  • The net round-trip trade across all stocks across the five indices is estimated at HK$50bn (US$6.4bn). There is size to trade in a lot of stocks.
  • Xiaomi (1810 HK) is the biggest buy due to HSIII Index inclusion and capping, while Alibaba (9988 HK) is the biggest capping sell.

PC Partner: Delisting in HK on 14 January 2026, Only on SGX Going Forward

By Nicolas Van Broekhoven

  • PC Partner (1263 HK) announced it was completing its delisting from HK and moving to Singapore
  • The move to Singapore was a “life or death” situation for the company, as staying in HK precluded it from having access to Nvidia’s latest chips
  • 2026 will be a crucial year to determine PC Partner’s future outlook

Hong Ra-Hee To Give 1.8 Million Shares of Samsung C&T to Her Son Lee Jae-Yong

By Douglas Kim

  • It was reported that Hong Ra-Hee plans to give all of her 1,808,577 shares in Samsung C&T (1.06% stake) to her son Lee Jae-Yong on 2 January 2026. 
  • After this stake transfer, Lee Jae-Yong’s stake in Samsung C&T will rise to 20.82% and Hong Ra-Hee will no longer have any stake in Samsung C&T. 
  • Higher ownership of Samsung C&T by Lee Jae-Yong will likely place a bigger focus on Samsung C&T, especially on its importance as a quasi-holding company of the entire Samsung Group. 

Primer: Telekomunikasi Indonesia (TLKM IJ) – Dec 2025

By αSK

  • Dominant Market Leader: As Indonesia’s largest state-owned telecommunications provider, Telkom holds a commanding market share in both mobile (through its subsidiary Telkomsel) and fixed broadband services, providing a strong foundation for stable revenue generation.
  • Strategic Asset Monetization: The company is pursuing a value-unlocking strategy by spinning off its fiber assets. This move, coupled with plans to bring in a strategic partner, aims to improve capital efficiency and potentially lead to a significant re-rating of the company’s valuation.
  • Attractive Shareholder Returns: Telkom consistently delivers strong returns to shareholders, evidenced by a high dividend yield and a formal commitment to dividend payouts. The company’s strong cash flow generation supports this policy.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Meesho – Potential Play on Value E-Commerce

By Himanshu Dugar

  • Meesho has positioned itself as a value-shopping platform catering to rural consumers and small sellers. It charges the seller only for fulfillment and advertising while bringing value deals for consumers
  • We believe Meesho has a right to win in the value-shopping category ahead of Flipkart/Amazon with its focus on pricing vs quality/convenience. However, it may not attract high-spending aspirational consumers
  • IPO valuation at $5.6bn(5x FY25 sales) is relatively cheap vs listed e-commerce peers (6-13x). Closest peer Flipkart was most recently valued at $35bn (14x FY25 revenues).

Readcloud Ltd – Driving growth through the schools businesses

By RaaS Research Group (RaaS)

  • ReadCloud Limited (ASX:RCL) services the education and training sectors through the provision of digital learning content, proprietary interactive technology and support for students and educators.
  • The company released its FY25 full-year result (30 September year-end) but many of the data points had been pre-released so there were no real surprises.
  • The core strategic Australian schools-facing businesses in eBooks and VET-in-Schools (collectively 85% of FY25 group sales revenue) delivered strong results, with VET-in-Schools the standout growing revenue at 26% to $5.7m and continuing to deliver gross margins exceeding 90%.

Fair Isaac (FICO): High-Margin Scores Franchise With Structural Pricing Power…

By Baptista Research

  • Fair Isaac Corporation (FICO) presented an earnings report for the fourth quarter of 2025 that highlights both the strengths and challenges facing the company.
  • Revenues for the quarter reached $516 million, a 14% increase compared to the previous year, and for the full fiscal year, revenues totaled $1.991 billion, up 16% year-over-year.
  • In their software segment, revenues were $204 million, with a mixed outlook.

Ad-Tech Primer: Investing in the Future of Digital Advertising

By Atrium Research

  • Public ad-tech equities are trading at historically low multiples, especially in Canada, despite consistent positive revenue growth and a pivot toward margin expansion.
  • Regulatory disruption and cookie deprecation are accelerating the shift to first-party data, contextual targeting, and AI-driven personalization.
  • Emerging channels like Connected TV and Retail Media are expanding monetization potential, creating asymmetric upside for nimble, vertically focused platforms.

Intel (INTC.US): Apple M-Series in 2027; Intel 18A Is the Key.

By Patrick Liao

  • Apple (AAPL US) may outsource iPad CPU production to Intel in 2027.
  • U.S. semiconductor reshoring faces fundamental structural barriers, and Trump is trying to blame this by pushing TSMC to move advanced manufacturing technology to the U.S. 
  • The key variable remains Intel’s 18A execution. However, Intel’s current CEO, Lip-Bu Tan, has not demonstrated an aggressive stance so far.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: XD Inc., Tsuruha Holdings, ICICI Bank Ltd, Quanta Computer, Genting Malaysia, UltraGreen.AI, Xiaomi and more

By | Daily Briefs, Most Read

In today’s briefing:

  • [Japan M&A] Possible Partial TSURUHA (3391 JP) Tender Changes – More Accretion! Smaller Tender?
  • KWEB Index Rebalance: 5 Adds & A Delete
  • [Japan Partial Tender] AEON (8267) Partial Offer for TSURUHA (3391) Announced at ¥2,900/Share
  • NIFTY Bank Index: Methodology Changes Announced; US$1.4bn Trade in Tranches
  • HEM: Dec-25 Views & Challenges
  • TIP Customized Taiwan Select High Dividend Index Rebal Preview: 8 Changes; US$8bn Trade
  • Genting Malaysia (GENM MK): Offer Closes As New York Casino Licence Awarded
  • Tsuruha (3391 JP): Aeon (8267 JP) Bumps Its Partial Tender Offer to JPY2,900
  • UltraGreen.ai IPO Trading: Attractive Pricing, Strong Tailwinds
  • HSI, HSCEI, HSTECH, HSIII, HSBIO Index Rebalance: US$6.4bn of Flows Post Capping (Dec 2025)


[Japan M&A] Possible Partial TSURUHA (3391 JP) Tender Changes – More Accretion! Smaller Tender?

By Travis Lundy

  • Today, post-close of its first day of trading as MergeCo, Tsuruha Holdings (3391 JP) announced 12 different investors who had voted against the deal filed for dissenting shareholder share repurchase.
  • This covers 27.154mm shares – a bit more than what Orbis owned when they last filed (25.5mm shs) and is just over half the AGM dissension.
  • This creates some weirdness. A 5+% buyback is strong accretion, but “fair price” is a question, and it could mean smaller tender offer quantity and larger eventual index selldowns.

KWEB Index Rebalance: 5 Adds & A Delete

By Brian Freitas


[Japan Partial Tender] AEON (8267) Partial Offer for TSURUHA (3391) Announced at ¥2,900/Share

By Travis Lundy

  • Tsuruha Holdings (3391 JP) had been planning to release a Medium Term Management Plan this month BUT stock prices are higher, goodwill effects changed, so they announced a “Vision” instead. 
  • Today post-close, Aeon Co Ltd (8267 JP) announced its Partial Tender Offer on TSURUHA (Japanese) at ¥2,900/share. Slightly lower than hoped. Much better than before. 
  • AEON obviously really did not want to bump, but they did, considering synergies and the desire to consummate the deal. The Tender Offer shrinks so minimum pro-ration is lower. 

NIFTY Bank Index: Methodology Changes Announced; US$1.4bn Trade in Tranches

By Brian Freitas


HEM: Dec-25 Views & Challenges

By Phil Rush

  • Volatile markets and policy guidance washed out, with pricing and forecasts little changed on the month.
  • Bailey is biased to ease, but the BoE is awakening to its inflation problem. It should cut less than dovishly priced.
  • Higher unemployment could move beyond a structural shift from policy to signal a less elevated neutral rate.

TIP Customized Taiwan Select High Dividend Index Rebal Preview: 8 Changes; US$8bn Trade

By Brian Freitas

  • The TIP Taiwan Select High Dividend ETF (00919 TW) tracks the TIP Customized Taiwan Select High Dividend Index and has an AUM of TWD 403bn (US$12.8bn).
  • We forecast 8 changes a side at the December rebalance with an estimated one-way turnover of 30.6% resulting in a round-trip trade of US$7.9bn.
  • The forecast adds have outperformed the forecast deletes over the last couple of weeks and we expect the adds to continue outperforming the deletes over the next few days.

Genting Malaysia (GENM MK): Offer Closes As New York Casino Licence Awarded

By David Blennerhassett

  • Genting Bhd (GENT MK)‘s unconditional Offer for Genting Malaysia (GENM MK) closed yesterday, the 1st December, with GENT holding 73.13%, up from 49.99% initially. 
  • The IFA previously opined the Offer to be NOT fair, and NOT reasonable. A bump in terms, long rumoured, failed to unfold. 
  • Yesterday, GENM was one of three applicants selected by New York’s Gaming Facility Location Board for a full commercial casino license in downtown New York.

Tsuruha (3391 JP): Aeon (8267 JP) Bumps Its Partial Tender Offer to JPY2,900

By Arun George

  • Tsuruha Holdings (3391 JP) announced a partial tender offer from Aeon Co Ltd (8267 JP) at JPY2,900, a 27.2% premium over the previously stated offer price of JPY2,280.
  • Aeon will acquire a maximum (upper limit) of 43.2 million shares (9.52% ownership ratio) such that it attains a 50.90% ownership ratio. There is no lower limit. 
  • The offer is above the midpoint of the IFA DCF valuation range and marginally below the JPY3,100 price Aeon paid in 2024 to acquire Oasis’ stake. 

UltraGreen.ai IPO Trading: Attractive Pricing, Strong Tailwinds

By Hong Jie Seow

  • UltraGreen.AI (2594794D SP) raised around US$400m in its Singapore IPO.
  • UltraGreen is a global leader in Fluorescence Guided Surgery (FGS), a surgical approach that helps doctors see things inside the body that are normally invisible under regular white light.
  • We have looked at the company’s background and pricing in our earlier note, in this note we talk about the trading dynamics.

HSI, HSCEI, HSTECH, HSIII, HSBIO Index Rebalance: US$6.4bn of Flows Post Capping (Dec 2025)

By Brian Freitas

  • The December rebalance of the Hang Seng family of indices will use today’s closing prices to cap the index constituent weights.
  • The net round-trip trade across all stocks across the five indices is estimated at HK$50bn (US$6.4bn). There is size to trade in a lot of stocks.
  • Xiaomi (1810 HK) is the biggest buy due to HSIII Index inclusion and capping, while Alibaba (9988 HK) is the biggest capping sell.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Financials: Aditya Birla Capital Ltd, HDFC Bank, KakaoBank , Wealthfront Corporation, Mercia Asset Management, Nexi SpA, Realgate , Target Healthcare REIT PLC, Central Reinsurance and more

By | Daily Briefs, Financials

In today’s briefing:

  • NIFTY200 Momentum30 Index Rebalance Preview: 64% One-Way Turnover & US$1.8bn Trade
  • HDFC Bank (HDFCB IN): Tactical Outlook Post–NIFTY Bank Index Overhaul
  • Primer: KakaoBank (323410 KS) – Dec 2025
  • Wealthfront Corporation (WLTH): Financial Platform Sets Terms Seeking North of $2.0b Valuation
  • Mercia Asset Management: EBITDA & margin up again, undervaluation rises
  • Payment Companies – Our 2026 High Conviction Ideas
  • (02 Dec 2025) Real Gate <5532> — Fisco Company Research
  • Target Healthcare REIT — Accretive asset recycling progressing
  • Primer: Central Reinsurance (2851 TT) – Dec 2025


NIFTY200 Momentum30 Index Rebalance Preview: 64% One-Way Turnover & US$1.8bn Trade

By Brian Freitas

  • There could be 19 constituent changes for the Nifty200 Momentum 30 Index that will be implemented at the close on 30 December.
  • If all changes are on expected lines, one-way turnover is estimated at 64.2% and that will result in a round-trip trade of INR 163bn (US$1.8bn).
  • The adds have outperformed the deletes in the short-term. With the index based on momentum, there could be further gains over the next couple of weeks.

HDFC Bank (HDFCB IN): Tactical Outlook Post–NIFTY Bank Index Overhaul

By Nico Rosti


Primer: KakaoBank (323410 KS) – Dec 2025

By αSK

  • KakaoBank is a dominant digital-only bank in South Korea, leveraging the vast user base of the KakaoTalk messenger platform to achieve significant market penetration and rapid growth. Its branchless model provides a structural cost advantage over traditional incumbents.
  • The bank is pursuing an aggressive growth strategy focused on expanding its customer base to 30 million and total assets to KRW 100 trillion by 2027. Key initiatives include diversifying into new loan products, enhancing platform services (e.g., advertising, loan comparison), and expanding internationally into markets like Indonesia and Thailand.
  • While growth has been robust, the company faces significant risks from intense competition from other digital banks (K-Bank, Toss Bank) and traditional banks’ digital offerings. Furthermore, regulatory uncertainty, particularly concerning its largest shareholder, Kakao Corp., and potential government measures to manage household debt, presents a material headwind.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Wealthfront Corporation (WLTH): Financial Platform Sets Terms Seeking North of $2.0b Valuation

By IPO Boutique

  • Wealthfront targets digital-native high earners, with 1.3 million funded clients and $88.2 billion in platform assets, driving strong client retention and organic growth.
  • The IPO offers 34.6 million shares at $12–$14, raising $255.2 million, with proceeds supporting working capital, debt repayment, and potential acquisitions.
  • The company demonstrates robust financial performance: 26% year-over-year revenue growth, 36% net income margins, and a proven product-led growth strategy supported by strong client engagement.

Mercia Asset Management: EBITDA & margin up again, undervaluation rises

By Equity Development

  • H1-26 (to 30 Sep 25) saw EBITDA jump 14% y-o-y to £4.2m and EBITDA margin up from 20.8% to 24.6%.
  • Impressively, this was achieved in a muted period for portfolio activity, with revenue slightly down from £17.6m to £17.2m.
  • AUM was marginally up at £2.0bn.

Payment Companies – Our 2026 High Conviction Ideas

By Victor Galliano

  • Our key picks for 1H 2026 are driven by fundamental valuations, margin and growth prospects; top of our buy list is Nexi, with PagSeguro in second place
  • Our key sell is Affirm; the increasingly competitive BNPL market is a potential “banana skin” for its premium growth forecasts, coupled with potentially worsening consumer credit delinquency
  • Klarna is one to watch in 1H 2026, but it is not there yet; the share price’s underwhelming performance post-IPO reflects the competitive BNPL market, especially in the US

(02 Dec 2025) Real Gate <5532> — Fisco Company Research

By FISCO

Key points (machine generated)

  • Realgate, listed on the Tokyo Stock Exchange under code 5532, reported an operating profit over 1 billion yen for the fiscal year ending September 2025.
  • Founded in 2009 and led by President Yutaka Iwamoto, Realgate focuses on revitalizing old buildings in urban areas into flexible workspaces.
  • The company has shown consistent revenue growth for 16 periods and became a consolidated subsidiary of CyberAgent in July 2021, leading to its listing in June 2023.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


Target Healthcare REIT — Accretive asset recycling progressing

By Edison Investment Research

Target Healthcare REIT has acquired three operational care homes and one new development for a total of £45m, deploying more than half the proceeds of its recent nine-home portfolio disposal. The high-quality homes, let to a strong new but established tenant, have been acquired at an accretive blended net initial yield of more than 6%. With significant remaining available capital, and a strong pipeline of similarly attractive opportunities, we expect acquisitions, in combination with indexed rent reviews, to drive continuing earnings and DPS growth.


Primer: Central Reinsurance (2851 TT) – Dec 2025

By αSK

  • Dominant Market Position with a Wide Moat: As the sole domestic reinsurance company in Taiwan, Central Reinsurance holds a significant competitive advantage, benefiting from strong relationships with local clients and a deep understanding of the domestic market.
  • Strong Financial Performance and Shareholder Returns: The company has demonstrated robust growth in net income and has a track record of attractive dividend payouts, underscored by a very strong capital and earnings position.
  • Exposure to Catastrophe Risk and Geographic Concentration: The company’s earnings are inherently volatile due to its exposure to natural catastrophes, particularly earthquakes and typhoons in its geographically concentrated Taiwanese market.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Tsuruha Holdings, Mitra Adiperkasa, Indofood Sukses Makmur Tbk P, Afya Ltd, Mao Geping Cosmetics, Orion Holdings, Lands’ End Inc, Dometic Group Ab, Essity and more

By | Consumer, Daily Briefs

In today’s briefing:

  • [Japan Partial Tender] AEON (8267) Partial Offer for TSURUHA (3391) Announced at ¥2,900/Share
  • Tsuruha (3391 JP): Aeon (8267 JP) Bumps Its Partial Tender Offer to JPY2,900
  • Mitra Adiperkasa (MAPI IJ) – Recovery in Motion
  • Primer: Indofood Sukses Makmur Tbk P (INDF IJ) – Dec 2025
  • Primer: Afya Ltd (AFYA US) – Dec 2025
  • Mao Geping IPO Lockup – US$4.7bn Lockup Release for Founders and Pre-IPO Investors
  • Primer: Orion Holdings (001800 KS) – Dec 2025
  • LE: 3Q Preview: Opportunities Becoming More Obvious; Reiterate Buy, $20 PT
  • Primer: Dometic Group Ab (DOM SS) – Dec 2025
  • Primer: Essity (ESSITYA SS) – Dec 2025


[Japan Partial Tender] AEON (8267) Partial Offer for TSURUHA (3391) Announced at ¥2,900/Share

By Travis Lundy

  • Tsuruha Holdings (3391 JP) had been planning to release a Medium Term Management Plan this month BUT stock prices are higher, goodwill effects changed, so they announced a “Vision” instead. 
  • Today post-close, Aeon Co Ltd (8267 JP) announced its Partial Tender Offer on TSURUHA (Japanese) at ¥2,900/share. Slightly lower than hoped. Much better than before. 
  • AEON obviously really did not want to bump, but they did, considering synergies and the desire to consummate the deal. The Tender Offer shrinks so minimum pro-ration is lower. 

Tsuruha (3391 JP): Aeon (8267 JP) Bumps Its Partial Tender Offer to JPY2,900

By Arun George

  • Tsuruha Holdings (3391 JP) announced a partial tender offer from Aeon Co Ltd (8267 JP) at JPY2,900, a 27.2% premium over the previously stated offer price of JPY2,280.
  • Aeon will acquire a maximum (upper limit) of 43.2 million shares (9.52% ownership ratio) such that it attains a 50.90% ownership ratio. There is no lower limit. 
  • The offer is above the midpoint of the IFA DCF valuation range and marginally below the JPY3,100 price Aeon paid in 2024 to acquire Oasis’ stake. 

Mitra Adiperkasa (MAPI IJ) – Recovery in Motion

By Angus Mackintosh

  • Mitra Adiperkasa stands out as Indonesia’s leading retailers, with an impressive portfolio of brands across segments, a dominant presence in major malls across Indonesia, and a strong online presence. 
  • MAPI booked a solid set of results in 3Q2025, with momentum continuing into October, as consumer sentiment has started to improve, with active outperforming. Digital, F&B, and fashion are improving  
  • The company’s international business is seeing better performance, especially in Thailand and the Philippines, with expansion remaining on track, and management expressing a more optimistic view for 4Q2025 and beyond.

Primer: Indofood Sukses Makmur Tbk P (INDF IJ) – Dec 2025

By αSK

  • Indofood is a vertically integrated food solutions giant in Indonesia, poised to benefit from the country’s favorable demographics and rising consumer spending.
  • The Agribusiness segment, particularly palm oil, is a significant growth driver, supported by strong commodity prices and government biodiesel mandates.
  • While the company exhibits strong top-line growth and market leadership, it faces risks from commodity price volatility, currency fluctuations, and margin pressures in its consumer branded products segment.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Afya Ltd (AFYA US) – Dec 2025

By αSK

  • Dominant Market Leader with Strong Pricing Power: Afya is the largest medical education group in Brazil, a market characterized by high demand and significant barriers to entry. This position allows for consistent tuition fee increases and maintains high occupancy rates (100% in medical programs), ensuring predictable revenue growth from the maturation of its existing medical school seats.
  • Integrated Ecosystem Driving Lifetime Value: The company is successfully transitioning from a pure education provider to an end-to-end, physician-centric ecosystem. This strategy combines its core medical school offerings with a growing suite of digital health tools and continuing education, aiming to capture value throughout a physician’s entire career.
  • Disciplined M&A Strategy and Solid Financials: Afya has a proven track record of growth through strategic acquisitions, funded by strong operating cash flow. The company maintains a healthy balance sheet with low leverage, providing flexibility for future M&A, share buybacks, and the recent initiation of dividend payments.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Mao Geping IPO Lockup – US$4.7bn Lockup Release for Founders and Pre-IPO Investors

By Sumeet Singh

  • Mao Geping Cosmetics (1318 HK) raised around US$345m in its Hong Kong IPO. The lockup on its founders and pre-IPO investors is set to expire soon.
  • Mao Geping Cosmetics (MGC) operates in the premium beauty segment. Via its two brands, MAOGEPING and Love Keeps, the firm offers a wide range of Color cosmetics and Skincare products.
  • In this note, we will talk about the lockup dynamics and possible placement.

Primer: Orion Holdings (001800 KS) – Dec 2025

By αSK

  • Orion Holdings is a leading South Korean confectionery company with a strong brand portfolio, including the iconic ‘Choco Pie’, and a significant, growing presence in key international markets such as China, Vietnam, and Russia.
  • The company is strategically diversifying its business into new growth areas, including beverages, convenient meal replacements, and biotechnology, to build a more comprehensive food and healthcare enterprise.
  • Despite robust growth in revenue and net income, the company’s market capitalization has underperformed, suggesting a potential valuation disconnect that may present an opportunity for investors.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


LE: 3Q Preview: Opportunities Becoming More Obvious; Reiterate Buy, $20 PT

By Small Cap Consumer Research

  • We are reiterating our Buy rating, projections and $20 price target for Lands’ End with the company reporting 3QFY25 (October) results before the open on Tuesday.
  • We believe, as the company begins to: 1) anniversary the shift to deeper levels of licensed goods/selling segments; 2) continues their focus on lifestyle driven looks and offering key solutions for their customer base (increasingly driven by customization), and 3) further expands the Outfitters uniform business, top line growth will become more obvious and, even more so, margin expansion will drive material free cash flow and EPS upside.
  • As such, we remain highly positive on the overall potential for LE and reiterate our Buy rating and $20 price target

Primer: Dometic Group Ab (DOM SS) – Dec 2025

By αSK

  • Dometic is a global leader in the niche market for mobile living solutions, with a strong brand and extensive distribution network. However, the company is currently navigating a challenging macroeconomic environment characterized by weakened demand in the key Recreational Vehicle (RV) and Marine markets.
  • Recent financial performance reflects industry headwinds, with declining revenues and a net loss in the most recent full year. Management is implementing a global restructuring program to improve efficiency and profitability, which is showing early signs of success with improved margins and strong cash flow generation.
  • The company’s valuation appears inexpensive on some metrics like Price-to-Book and EV/Sales, but the lack of profitability (negative P/E) reflects the current operational challenges. A recovery in earnings is contingent on a stabilization of its end markets and the successful execution of its cost-saving initiatives.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Essity (ESSITYA SS) – Dec 2025

By αSK

  • Essity is a global hygiene and health products leader, well-positioned to capitalize on long-term growth trends such as aging populations and rising hygiene standards in emerging markets.
  • The company is demonstrating a commitment to improving profitability, evidenced by recent margin recovery, ongoing cost-saving initiatives, and a strategic portfolio shift towards higher-margin segments following the divestment of its Vinda stake.
  • Despite a stable demand profile, Essity faces significant headwinds from volatile input costs, intense competition from branded and private-label players, and recent volume pressures in key segments like Professional Hygiene.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: UltraGreen.AI, Hebei Changshan Biochemical Pharm, 3SBio Inc, Lumexa Imaging Holdings, Shanghai Bao Pharmaceuticals, Vivos Therapeutics , Kalbe Farma, Mandi, NewGenIVF Group Ltd, Shanghai Kaibao Pharmaceutical Co,Ltd. and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • UltraGreen.ai IPO Trading: Attractive Pricing, Strong Tailwinds
  • Quiddity ChiNext & ChiNext 50 Dec25 Results: ~US$1.5bn Combined One-Way Flow; Multiple Surprises
  • 3SBio (1530 HK) Placement: 3SBio’s Pipeline Strength, An Indirect Stake in Mandi Makes It Attractive
  • Lumexa Imaging Holdings, Inc. (LMRI): Diagnostic Imaging Service Seeking up to $1.9b Valuation
  • Shanghai Bao Pharmaceuticals IPO: Niche Drug Candidates Entail Long-Term Growth Prospect
  • VVOS: Strong Quarter Builds Platform for Continuing Growth Momentum
  • Primer: Kalbe Farma (KLBF IJ) – Dec 2025
  • Pre-IPO Mandi Inc. – The Business Model, the Concerns and the Valuation
  • NIVF: YTD Financial Results Generally Tracking Our 2025 Full-Year Forecasts Plenty of Growth Catalysts on Tap
  • Primer: Shanghai Kaibao Pharmaceutical Co,Ltd. (300039 CH) – Dec 2025


UltraGreen.ai IPO Trading: Attractive Pricing, Strong Tailwinds

By Hong Jie Seow

  • UltraGreen.AI (2594794D SP) raised around US$400m in its Singapore IPO.
  • UltraGreen is a global leader in Fluorescence Guided Surgery (FGS), a surgical approach that helps doctors see things inside the body that are normally invisible under regular white light.
  • We have looked at the company’s background and pricing in our earlier note, in this note we talk about the trading dynamics.

Quiddity ChiNext & ChiNext 50 Dec25 Results: ~US$1.5bn Combined One-Way Flow; Multiple Surprises

By Janaghan Jeyakumar, CFA

  • The June 2025 index review results for the ChiNext and ChiNext 50 indices were announced after market close on Friday 28th November 2025.
  • There will be eight changes for the ChiNext index and five changes for the ChiNext 50 index.
  • The ChiNext and ChiNext 50 index rebal events could trigger US$1.1bn and US$379mn in one-way flows respectively.

3SBio (1530 HK) Placement: 3SBio’s Pipeline Strength, An Indirect Stake in Mandi Makes It Attractive

By Tina Banerjee

  • 3SBio Inc (1530 HK) announced the placement of 105.2M shares for subscription at HK$29.62 per share.
  • The company intends to use 80% of the net proceeds for R&D-related expenditures on innovative drug candidates and the rest 20% for working capital and other general corporate purpose.
  • The placement provides an indirect way of subscribing to Mandi shares. We reiterate our bullish stance on 3SBio with a 25-30% upside scope in the near term.

Lumexa Imaging Holdings, Inc. (LMRI): Diagnostic Imaging Service Seeking up to $1.9b Valuation

By IPO Boutique

  • Lumexa advances its IPO with a 25M-share offering, targeting a $1.6–$1.9B valuation and expecting over $427M in primary proceeds.
  • As the second-largest U.S. outpatient imaging provider, the company operates 184 centers with strong referral networks, high-growth markets, and leadership in advanced imaging.
  • Revenue growth remains steady and diversified across modalities, supporting a stable sector profile and an attractive risk-reward setup backed by a strong underwriting syndicate.

Shanghai Bao Pharmaceuticals IPO: Niche Drug Candidates Entail Long-Term Growth Prospect

By Tina Banerjee

  • Shanghai Bao Pharmaceuticals has launched HK IPO to raise ~$128M by offering~38M H shares at HK$26.38 per share. Subscriptions will close on December 5, with expected listing on December 10.
  • The company intends to use the IPO proceeds for R&D and commercialization of core products, advancement of other existing pipeline assets, enhance and scale up manufacturing capabilities.           
  • Core products of Bao Pharmaceutical are differentiated and niche, thereby limiting competition threat. These products have demonstrated superior efficacy and safety in clinical trials and targets sizable patient population.

VVOS: Strong Quarter Builds Platform for Continuing Growth Momentum

By Water Tower Research

  • SCN revenue-powered 3Q25. Vivos Therapeutics (NASDAQ: VVOS) delivered a strong quarter, reporting a 76% Y/Y revenue surge from $3.9 million to $6.8 million, fueled by the first full-quarter contribution from Sleep Center of Nevada (SCN), which Vivos acquired on June 10, 2025. 
  • The $2.9-million revenue accretion consisted of a $2.2-million increase in OSA sleep testing services, primarily generated by SCN, and $1.3 million generated from treatment centers known as Sleep and Airway Medicine Centers (SAMCs) launched at two SCN locations in Las Vegas. 
  • This was partially offset by a $0.8-million drop in VIP revenue, a deliberate diminution from this source, reflecting management’s strategic decision to pivot away from the legacy channel.

Primer: Kalbe Farma (KLBF IJ) – Dec 2025

By αSK

  • Kalbe Farma is the largest publicly-listed pharmaceutical company in Indonesia and Southeast Asia, with a diversified business model spanning four key divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution & Logistics.
  • The company is well-positioned to capitalize on the favorable long-term tailwinds of the Indonesian healthcare industry, which is the largest in ASEAN and projected to continue its strong growth trajectory, driven by a large population, a rising middle class, and the national health insurance scheme (JKN/BPJS).
  • Despite recent margin pressures from a shifting product mix and currency fluctuations, the stock appears attractively valued, trading at a significant discount to its historical mean. A rebound in revenue, coupled with stable raw material prices and a resilient core profit outlook, presents a compelling investment case.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Pre-IPO Mandi Inc. – The Business Model, the Concerns and the Valuation

By Xinyao (Criss) Wang

  • Mandi’s business is quite focused. In the short-term, Minoxidil will continue to be the main performance driver for Mandi. The performance contribution of Winlevi and Mandi’s semaglutide would be uncertain. 
  • The concern here is the declining growth rate due to VBP and increasing competition. Based on our forecast, growth of the next three years would be maintained at 15-20% YoY.
  • An aggressive valuation range for Mandi is RMB34-43 billion. However, due to VBP/increasing competition, a relatively conservative P/S range is 10-20x. If based on 2025 forecast, valuation is RMB17.2-34.3 billion.


Primer: Shanghai Kaibao Pharmaceutical Co,Ltd. (300039 CH) – Dec 2025

By αSK

  • Shanghai Kaibao is a specialized pharmaceutical company focused on Traditional Chinese Medicine (TCM), with its patented, exclusive product, Tanreqing Injection, serving as the primary revenue and profit driver. This product is a leading treatment for respiratory illnesses like bronchitis and pneumonia in China.
  • The company has demonstrated a remarkable financial turnaround, evidenced by a 3-year net income CAGR of 38.91%. This growth follows a period of stagnation, signaling a potential resurgence, supported by high and stable gross margins consistently above 76%.
  • Significant risks loom from high product concentration on Tanreqing and the stringent Chinese regulatory environment. Potential government-mandated price reductions through the National Reimbursement Drug List (NRDL) negotiations and competition from substitute treatments pose material threats to future profitability.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: SBI Shinsei Bank, ICICI Bank Ltd, EURO/US DOLLAR, AUD, Superbank, Citic Securities (H), NS Group, Priority Technology Holdings I, China Vanke and more

By | Daily Briefs, Financials

In today’s briefing:

  • SBI Shinsei Bank (8303 JP) IPO: Price Range Is Attractive
  • NIFTY Bank Index: Methodology Changes Announced; US$1.4bn Trade in Tranches
  • SBI Shinsei Bank IPO – Stronger Support, Decent Valuation
  • Global FX Outlook 2026: Bearish USD, Bullish Beta
  • Global FX Volatility Outlook 2026
  • Superbank IPO: Superb Story, Decent Entry Point
  • Hong Kong December 2025 Monthly Covered Call Report
  • NS Group IPO – Deal Downsized; Pricing Looks Digestible Now
  • Active Merger Arbitrage and Privatization Opportunities: Strategic Reviews, Buyouts, and More
  • Lucror Analytics – Morning Views Asia


SBI Shinsei Bank (8303 JP) IPO: Price Range Is Attractive

By Arun George


NIFTY Bank Index: Methodology Changes Announced; US$1.4bn Trade in Tranches

By Brian Freitas


SBI Shinsei Bank IPO – Stronger Support, Decent Valuation

By Sumeet Singh

  • SBI Shinsei Bank (8303 JP), a Japanese financial institution, aims to raise around US$2.1bn in its Japan listing.
  • SBI Shinsei Bank (SBISB) is a Japanese financial institution providing a range of financial products and services to both individual and institutional customers.
  • We looked at the company’s past performance in our earlier note. In this note, we talk about valuations.

Global FX Outlook 2026: Bearish USD, Bullish Beta

By At Any Rate

  • Global team focusing on what’s new for 2026 in terms of market outlook
  • Bullish on Eurodollar, expecting more modest gains due to US resilience
  • Dollar maintains yield supremacy, but new cyclical currencies emerging as carry efficient options for hedging volatility shocks

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Global FX Volatility Outlook 2026

By At Any Rate

  • Macro crew discussed a benign outlook on carry fairly risk on climate for the first half of the year
  • FX vols expected to be fairly contained in 2026 due to factors like US growth and central bank activity
  • Themes for positioning in 2026 include bullish European growth, antipodean FX, and bearish Yen outlook

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Superbank IPO: Superb Story, Decent Entry Point

By Hong Jie Seow

  • Superbank (SUPA IJ) aims to raise around US$184m in its Indonesia IPO.
  • Superbank is a digital bank in Indonesia operating through a combination of ecosystem-led distribution and its own standalone mobile application.
  • In our previous note, we looked at its past performance. In this note, we will talk about valuations.

Hong Kong December 2025 Monthly Covered Call Report

By Nicholas Pezolano

  • Top Hong Kong Stock Exchange listed covered call candidates for the month of December.
  • The top 10 provide an average ~6.9% premium with a potential ~8.4% upside P&L if exercised.
  • Investors with a neutral 1-month view on the underlying can seek to generate income.

NS Group IPO – Deal Downsized; Pricing Looks Digestible Now

By Akshat Shah

  • NS Group (471A JP) (NSG) is one of Japan’s leading rent guarantee service providers, offering payment guarantee and rent collection solutions to property owners and management companies.
  • NSG aims to raise around US$220m in its Japan IPO via an entirely secondary offering, marking Bain Capital’s full exit from the company.
  • In our previous note, we looked at the firm’s past performance and peer comparison. In this note, we talk about the pricing updates and IPO valuations.

Active Merger Arbitrage and Privatization Opportunities: Strategic Reviews, Buyouts, and More

By Special Situation Investments

  • Priority Technology received a non-binding privatization offer from its founder at $6-$6.15/share, with a 11%-14% spread.
  • Generation Bio completed restructuring, now a cash shell with net cash at $7.6/share, 50% above current price.
  • Sotherly Hotels’ preferred shares trade with a 12-14% spread to offer price, common shares at 5% spread.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: China Vanke, Genting Berhad, Meituan
  • UST yields climbed 1-3 bps on Friday, albeit there were no material catalysts as the market returned after Thanksgiving. The yield on the 2Y UST rose 1 bp to 3.49%, while that on the 10Y UST was up 2 bps at 4.01%. Equities climbed on thin trading in a shortened postholiday session. The S&P 500 and Nasdaq advanced 0.5% and 0.7% to 6,849 and 23,366, respectively.
  • China’s November official manufacturing PMI edged up to 49.2 (49.4 e / 49.0 p), albeit remaining in contraction territory for the eighth straight month. The non-manufacturing PMI slipped to 49.5 (50.0 e / 50.1 p), with the composite PMI declining to 49.7 (50.0 p).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: African Gold Ltd, Havilah Resources, Venus Metals Corp, AUD and more

By | Australia, Daily Briefs

In today’s briefing:

  • African Gold Ltd (A1G AU) Enters Scheme With Montage Gold (MAU CN)
  • The Copper Sleeper that Nobody’s Watching (Anthony Kavanagh)
  • Venus Metals Faces Hostile Takeover Bid from QGold Amid Potential for Higher Offers and Asset Valuation Discrepancies
  • Global FX Volatility Outlook 2026


African Gold Ltd (A1G AU) Enters Scheme With Montage Gold (MAU CN)

By David Blennerhassett

  • The gold rush continues with another Canadian outfit bidding to take over an Aussie-listed West African gold play. 
  • Junior miner African Gold (A1G AU)has entered into a Scheme with Montage Gold (MAU CN). African Gold shareholders will receive 0.0628 new MAU shares for every A1G share.
  • That backs out an implied value of A$0.50/share. Independent directors, holding 11.6% of shares out, are supportive. Montage holds 17.3%. Clean deal.

The Copper Sleeper that Nobody’s Watching (Anthony Kavanagh)

By Money of Mine

  • The speaker discusses their interest in an intriguing South Australian undeveloped copper stock called Havilah (HAV)
  • The speaker shares their initial encounter with the company in 2022 and their impression of its potential value and optionality of assets

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Venus Metals Faces Hostile Takeover Bid from QGold Amid Potential for Higher Offers and Asset Valuation Discrepancies

By Special Situation Investments

  • QGold’s hostile takeover offer for Venus Metals at A$0.17/share is expected to increase, with VMS stock trading at A$0.195/share.
  • VMC’s assets in Rox Resources are valued at A$46m, with a 1% net smelter royalty potentially undervalued due to outdated assumptions.
  • Christopher Wallin’s QGold has acquired a 26% stake in VMC and a 9% stake in Rox Resources, indicating strategic interest.

Global FX Volatility Outlook 2026

By At Any Rate

  • Macro crew discussed a benign outlook on carry fairly risk on climate for the first half of the year
  • FX vols expected to be fairly contained in 2026 due to factors like US growth and central bank activity
  • Themes for positioning in 2026 include bullish European growth, antipodean FX, and bearish Yen outlook

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: NIFTY Index Earning Revision (Nov): Eternal and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • NIFTY Index Earning Revision (Nov): Eternal, Hindalco Industries, Mahindra & Mahindra
  • CSI 100 Index Earning Revision (Nov): CHINA VANKE, PING AN INSURANCE, BOE, TCL
  • STAR50 Index Earning Revision (Nov): NATIONAL SILICON INDUSTRY, LOONGSON TECHNOLOGY
  • Hong Kong Connect Flows (November): Alibaba, Xiaomi
  • CSI 300 Index Earning Revision (Nov): DAWNING INFORMATION INDUSTRY, PING AN INSURANCE
  • TOPIX CORE 30 Index Earning Revision (Nov): Sumitomo Mitsui Financial, Honda Motor, SoftBank


NIFTY Index Earning Revision (Nov): Eternal, Hindalco Industries, Mahindra & Mahindra

By Ke Yan, CFA, FRM

  • We analysed the earning revision of component stocks of NIFTY in the past month.
  • We tabulated stocks with the top impact on index’s EPS, stocks’ EPS revision, and revenue revision.
  • We highlighted EPS revision on Eternal, Hindalco Industries, Mahindra & Mahindra, State Bank of India, HDFC Bank, Adani Enterprises, ICICI Bank, State Bank Of India, Hdfc Bank, Hindalco Industries.

CSI 100 Index Earning Revision (Nov): CHINA VANKE, PING AN INSURANCE, BOE, TCL

By Ke Yan, CFA, FRM

  • We analysed the earning revision of component stocks of CSI 100 in the past month.
  • We tabulated stocks with the top impact on index’s EPS, stocks’ EPS revision, and revenue revision.
  • We highlighted EPS revision on CHINA VANKE, PING AN INSURANCE, BOE TECHNOLOGY, TCL TECHNOLOGY, COSCO SHIPPING, GANFENG LITHIUM, Cosco Shipping, Ping An Insurance, China Vanke, Boe Technology, Tcl Technology.

STAR50 Index Earning Revision (Nov): NATIONAL SILICON INDUSTRY, LOONGSON TECHNOLOGY

By Ke Yan, CFA, FRM

  • We analysed the earning revision of component stocks of STAR50 in the past month.
  • We tabulated stocks with the top impact on index’s EPS, stocks’ EPS revision, and revenue revision.
  • We highlighted EPS revision on NATIONAL SILICON INDUSTRY, LOONGSON TECHNOLOGY, BIWIN STORAGE TECHNOLOGY, MONTAGE TECHNOLOGY, HWATSING TECHNOLOGY, Roborock, CSI SOLAR, National Silicon Industry, Roborock, Montage Technology, Hwatsing Technology.

Hong Kong Connect Flows (November): Alibaba, Xiaomi

By Ke Yan, CFA, FRM

  • We analyze the monthly Hong Kong Connect flows with our data engine.
  • We tabulate the top stocks by inflows, outflows, and holding by mainland investors.
  • We highlight flows of Alibaba, Xiaomi, HSTECH ETF, CNOOC, ICBC.

CSI 300 Index Earning Revision (Nov): DAWNING INFORMATION INDUSTRY, PING AN INSURANCE

By Ke Yan, CFA, FRM

  • We analysed the earning revision of component stocks of CSI 300 in the past month.
  • We tabulated stocks with the top impact on index’s EPS, stocks’ EPS revision, and revenue revision.
  • We highlighted EPS revision on DAWNING INFORMATION INDUSTRY, PING AN INSURANCE, JIANGSU EASTERN SHENGHONG, BOE, SPDB, CHINA VANKE, NATIONAL SILICON INDUSTRY.

TOPIX CORE 30 Index Earning Revision (Nov): Sumitomo Mitsui Financial, Honda Motor, SoftBank

By Ke Yan, CFA, FRM

  • We analysed the earning revision of component stocks of TOPIX CORE 30 in the past month.
  • We tabulated stocks with the top impact on index’s EPS, stocks’ EPS revision, and revenue revision.
  • We highlighted EPS revision on Sumitomo Mitsui Financial, Honda Motor, SoftBank, Toyota Motor, Sony, Sony Financial, Softbank, Toyota Motor, Sumitomo Mitsui Financial, Sony, Honda Motor, Sony Financial.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: 3SBio Placement: Partnership with Pfizer Going Well; Digestible Deal and more

By | Daily Briefs, ECM

In today’s briefing:

  • 3SBio Placement: Partnership with Pfizer Going Well; Digestible Deal
  • SBI Shinsei Bank (8303 JP) IPO: Price Range Is Attractive
  • SBI Shinsei Bank IPO – Stronger Support, Decent Valuation
  • Suzhou Novosense A/H Listing – Strong Growth but Lacks Margin Stability
  • Superbank IPO: Superb Story, Decent Entry Point
  • Meesho Ltd Pre-IPO – Mass-Market Player Scaling on Low-Cost, High-Frequency Commerce
  • NS Group IPO – Deal Downsized; Pricing Looks Digestible Now
  • Meesho IPO: Garmenting a Mass Market Play for Long-Term Growth
  • Cardinal Infrastructure Group Inc. (CDNL): Infrastructure Play Sets Terms for IPO
  • Pre-IPO TOP TOY International Group – The Industry, the Business and the Valuation Outlook


3SBio Placement: Partnership with Pfizer Going Well; Digestible Deal

By Nicholas Tan

  • 3SBio Inc (1530 HK) is looking to raise around US$400m from a primary placement.
  • The deal is a small one, representing 2.9 days of the stock’s three month ADV, and 3.9% of total shares outstanding.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

SBI Shinsei Bank (8303 JP) IPO: Price Range Is Attractive

By Arun George


SBI Shinsei Bank IPO – Stronger Support, Decent Valuation

By Sumeet Singh

  • SBI Shinsei Bank (8303 JP), a Japanese financial institution, aims to raise around US$2.1bn in its Japan listing.
  • SBI Shinsei Bank (SBISB) is a Japanese financial institution providing a range of financial products and services to both individual and institutional customers.
  • We looked at the company’s past performance in our earlier note. In this note, we talk about valuations.

Suzhou Novosense A/H Listing – Strong Growth but Lacks Margin Stability

By Sumeet Singh

  • Suzhou Novosense Microelectron (688052 CH), an analog chips producer, aims to raise around US$285m in its H-share listing.
  • According to Frost & Sullivan, in terms of revenue from analog chips in 2024, SNM ranked fifth among Chinese analog chip companies in the Chinese analog chip market.
  • We have looked at the past performance and likely A/H premium in our previous note. In this note, we talk about the IPO pricing.

Superbank IPO: Superb Story, Decent Entry Point

By Hong Jie Seow

  • Superbank (SUPA IJ) aims to raise around US$184m in its Indonesia IPO.
  • Superbank is a digital bank in Indonesia operating through a combination of ecosystem-led distribution and its own standalone mobile application.
  • In our previous note, we looked at its past performance. In this note, we will talk about valuations.

Meesho Ltd Pre-IPO – Mass-Market Player Scaling on Low-Cost, High-Frequency Commerce

By Akshat Shah

  • Meesho Ltd (1546271D IN) is looking to raise around US$607m in its upcoming India IPO. 
  • Meesho is an e-commerce marketplace, offering a wide assortment of products ranging from low cost unbranded products, regional and national brands at affordable prices to consumers.
  • In this note, we talk about the company’s historical performance.

NS Group IPO – Deal Downsized; Pricing Looks Digestible Now

By Akshat Shah

  • NS Group (471A JP) (NSG) is one of Japan’s leading rent guarantee service providers, offering payment guarantee and rent collection solutions to property owners and management companies.
  • NSG aims to raise around US$220m in its Japan IPO via an entirely secondary offering, marking Bain Capital’s full exit from the company.
  • In our previous note, we looked at the firm’s past performance and peer comparison. In this note, we talk about the pricing updates and IPO valuations.

Meesho IPO: Garmenting a Mass Market Play for Long-Term Growth

By Tina Banerjee

  • Meesho IPO will comprise a fresh issue of INR42.5B, and an OFS of 105.5M shares. The price band of the IPO has been fixed between INR105 and INR111 per share.
  • Meesho’s IPO will open for subscription on Wednesday, December 3 and close on Friday, December 5. The IPO is scheduled to list on the stock exchanges on Wednesday, December 10.
  • Meesho intends to utilize IPO proceeds for investment for cloud infrastructure, paying salaries of technology team, marketing and brand building initiative, and acquisition. The IPO is suitable for risk-seeking investors.

Cardinal Infrastructure Group Inc. (CDNL): Infrastructure Play Sets Terms for IPO

By IPO Boutique

  • Cardinal Infrastructure sets terms for its IPO and could raise up to $253 million if priced at the high end of the range. 
  • Cardinal Infrastructure offers full-service, in-house wet utility and site work solutions in fast-growing Southeastern markets, benefiting from strong demand, population growth, and reduced outsourcing needs.
  • A proven acquisition-led expansion strategy, deep customer relationships, and high repeat revenue underpin robust growth, a strong backlog, and successful market penetration in new geographies.

Pre-IPO TOP TOY International Group – The Industry, the Business and the Valuation Outlook

By Xinyao (Criss) Wang

  • Relying on MINISO’s mature retail system, TOP TOY has achieved scale accumulation rapidly.Real challenge lies in whether it can continuously create “blockbuster proprietary IPs” and reduce reliance on licensing model.
  • Due to smaller revenue proportion of proprietary IPs/overseas revenue and lower profit margin, valuation of TOP TOY should be lower than Pop Mart, but would be higher than MINISO.
  • If based on 2025 forecast, valuation is RMB9.3-11.2 billion. So, post-money valuation of US$1.3 billion after Series A financing is not cheap. Valuation premium space after IPO may be lower-than-expected.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars